ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,963.60
      0.59%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.535
      0.14%
      Bitcoin
      57,513.12
      1.42%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. InMed Pharmaceuticals Inc (INM)

      7. InMed Pharmaceuticals Inc (INM) News

      INM

      InMed Pharmaceuticals (INM)

      InMed Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INM
      DateTimeSourceHeadlineSymbolCompany
      06/24/20226:02AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:INMInMed Pharmaceuticals Inc
      06/22/20226:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      06/16/20226:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      06/14/20227:30AMGlobeNewswire Inc.InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin ConditionsNASDAQ:INMInMed Pharmaceuticals Inc
      06/10/20224:37PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      06/09/20227:30AMGlobeNewswire Inc.InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness SectorNASDAQ:INMInMed Pharmaceuticals Inc
      06/07/20226:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      06/06/20226:49PMGlobeNewswire Inc.InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq RulesNASDAQ:INMInMed Pharmaceuticals Inc
      06/06/20226:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      06/06/20226:03AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INMInMed Pharmaceuticals Inc
      06/02/20222:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      06/02/20222:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      06/02/20228:00AMGlobeNewswire Inc.InMed Pharmaceuticals Announces $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq RulesNASDAQ:INMInMed Pharmaceuticals Inc
      05/19/20224:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
      05/19/20224:23PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INMInMed Pharmaceuticals Inc
      05/18/20221:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      05/13/20227:32AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INMInMed Pharmaceuticals Inc
      05/13/20227:30AMGlobeNewswire Inc.InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business UpdateNASDAQ:INMInMed Pharmaceuticals Inc
      05/06/20222:51PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      05/05/20227:30AMGlobeNewswire Inc.InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCVNASDAQ:INMInMed Pharmaceuticals Inc
      04/28/20227:30AMGlobeNewswire Inc.InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research ExpertNASDAQ:INMInMed Pharmaceuticals Inc
      04/21/20222:47PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      04/21/20227:30AMGlobeNewswire Inc.InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness SectorNASDAQ:INMInMed Pharmaceuticals Inc
      04/20/20226:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
      04/19/20227:30AMGlobeNewswire Inc.InMed to Participate in Upcoming Investor Conferences in April and May 2022NASDAQ:INMInMed Pharmaceuticals Inc
      04/19/20226:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INMInMed Pharmaceuticals Inc
      04/08/20223:08PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INMInMed Pharmaceuticals Inc
      04/07/20224:47PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:INMInMed Pharmaceuticals Inc
      04/07/20224:47PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:INMInMed Pharmaceuticals Inc
      03/22/20226:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:INM

      Your Recent History

      NYSE
      ASR
      Grupo Aeroportuario Del ...
      Delayed Upgrade Clock